Physician profile
Madison Turner
NPI 1164063418
$6,036.35
in general payments reported to CMS, 2019-2025
37 companies · $1,490 in 2025
The $1,490 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $486 · 2022: $1,172 · 2023: $1,730 · 2024: $1,159 · 2025: $1,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,359 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,359.38 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $619.13 | 2022-2025 | General - Therapies, Enroute Transcarotid Stent, Watchman |
| Janssen Pharmaceuticals, INC | $564.42 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $560.06 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $475.85 | 2022-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $368.54 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral |
| Astrazeneca Pharmaceuticals LP | $350.47 | 2021-2024 | Farxiga, Andexxa, Brilinta |
| Biotronik INC. | $274.22 | 2021-2023 | Biomonitor, Edora 8 Dr-T |
| Alnylam Pharmaceuticals INC. | $270.12 | 2024-2025 | Onpattro, Amvuttra |
| Novartis Pharmaceuticals Corporation | $253.96 | 2022-2025 | |
| Cordis US Corp. | $247.56 | 2021-2024 | Radial 360, Saber, S.M.A.R.T. |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.14 | 2021-2024 | Jardiance |
| Novo Nordisk INC | $165.05 | 2024-2025 | Wegovy |
| Angiodynamics, INC. | $160.37 | 2023-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Daiichi Sankyo INC. | $157.51 | 2023-2025 | Injectafer |
| Lilly USA, LLC | $134.58 | 2022-2025 | Zepbound, Taltz |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $120.14 | 2022-2024 | Repatha |
| Smith+Nephew, INC. | $119.08 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $118.08 | 2023-2025 | |
| Abiomed | $113.88 | 2024-2025 | Impella |
| Philips North America LLC | $84.26 | 2023-2025 | (Ck4) Mcot, Mcot |
| Lexicon Pharmaceuticals, INC. | $76.45 | 2023-2024 | Inpefa |
| Veryan Medical Incorporated | $67.79 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $59.81 | 2024-2025 | Eliquis, Camzyos |
| Baxter Healthcare | $57.18 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Irhythm Technologies, INC. | $48.95 | 2022 | |
| Kestra Medical Technology Services, INC. | $42.35 | 2024 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $41.67 | 2022 | |
| Impulse Dynamics (USA) INC. | $38.28 | 2024 | Optimizer |
| Edwards Lifesciences Corporation | $33.66 | 2023 | |
| Bridgebio Pharma, INC. | $32.60 | 2025 | Attruby |
| Chiesi USA, INC. | $30.99 | 2024 | Kengreal, Cleviprex |
| Cardiovascular Systems INC. | $24.61 | 2022 | |
| Medtronic, INC. | $23.43 | 2022 | |
| Esperion Therapeutics, INC. | $18.65 | 2024 | Nexletol |
| Scpharmaceuticals INC. | $17.45 | 2024 | |
| Endologix LLC | $16.20 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $14.86 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.